1. Schrauzer GN. Selenium and cancer. In:Selenium in medicine and biology. Neve J and Favier A eds Berlin. New York:Walter de Gruyter & Co, 1988:251
|
2. Lippman SM, Kessler JF, Meyskens FL Jr. Retinoids as preventive and therapeutic anticancer agents(Part Ⅰ). Cancer Treat Rep, 1987, 71:391
|
3. 刘新光, 于树玉. 亚硒酸钠和维甲酸联合对HL-60细胞生长、分化的影响, 肿瘤防治研究, 1996, 23(4):209
|
4. 刘新光, 于树玉. 亚硒酸钠和维甲酸联合对HL-60细胞DNA与蛋白质合成和细胞周期的影响. 肿瘤, 1997, 17(1):4
|
5. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning. second edition. New York:Cold Spring Harbor Laboratory Press, 1989:1.38、10.13、7.53
|
6. Chomczynski P, Sacchi N. Single-step method of RNA isolaction by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem, 1987, 162:156
|
7. Leglise MC, Dent GA, Ayscue LH, et al. Leukemic cell maturation: Phenotypic variability and oncogene expression in HL-60 cells:A review. Blood Cells, 1988, 13:319
|
8. Bentley DL, Groudine M. A b1ock to elongation is largely responsible for decreased transcription of c-myc in differentiated HL-60 cells. Nature, 1986, 321:702
|
9. Mccachren SS Jr, Salehi Z, Weinberg JB, et al. Transcription interruption rnay be a common mechanism of c-myc regulation during HL-60 differentiation. Biochem Biophys Res Commun, 1988, 151:574
|
10 Grosso LE, Pitot HC, Modulation of c-myc expression in the HL-60 cell line. Biochem Biophys Res Commun, 1984, 119:473
|
11 于树玉. 硒预防肝癌的研究. 见:李冰主编. 肿瘤防治现状与进展. 北京:北京医科大学和中国协和医科大学联合出版社, 1994:24
|
12 Studzinski GP and Brelvi ZS. Expression of oncogenes c-myc and c-fos in non-terminal differentiation of HL-60 cells. Proc Amer Ass Cancer Res, 1986, 27:47
|
13 Liversey SA, Ng KW, Collier GR, et al. Effect of retinoic aeid on cellular content and human parathyroid hormone activation of cyclic adenosine 3’5’-monophosphate-dependent protein kinase isoenzyme in clonal rat osteogenic sarcoma cells. Cancer Res, 1985, 45:5734m
|
14 Kerr JFR and Winterford CM. Apoptosis Cancer, 1994, 73:2013
|